Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07747168

Predictive Value of Nutritional and Inflammatory Indices for Postoperative Complications After Bariatric Surgery

Bariatric surgery is an effective treatment for severe obesity, but postoperative complications remain an important cause of morbidity. Several nutritional and inflammatory biomarkers derived from routine preoperative blood tests have been proposed as predictors of postoperative outcomes; however, their comparative value in bariatric surgery has not been fully established.

This single-center retrospective cohort study will evaluate the ability of preoperative nutritional and inflammatory indices, including the Prognostic Nutritional Index (PNI), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and C-reactive Protein-to-Albumin Ratio (CAR), to predict 30-day postoperative complications following bariatric surgery. The study aims to identify the most clinically useful biomarker for preoperative risk stratification and optimization of perioperative care.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

General Hospital of Athens G Gennimatas

Athens, 11526, Greece

About this study

Bariatric surgery is the most effective treatment for severe obesity and obesity-related comorbidities. Despite advances in perioperative care, early postoperative complications continue to contribute to patient morbidity and healthcare utilization. Reliable preoperative risk stratification tools are therefore essential for identifying patients at increased risk and optimizing perioperative management.

Nutritional status and systemic inflammation have emerged as important determinants of surgical outcomes. Several composite indices calculated from routinely available laboratory parameters, including albumin, C-reactive protein, leukocyte subsets, and platelet counts, have demonstrated prognostic value in different surgical populations. However, evidence regarding their comparative predictive performance in bariatric surgery remains limited.

This single-center retrospective cohort study will include consecutive adult patients who underwent sleeve gastrectomy or gastric bypass procedures between 2023 and 2026. Preoperative nutritional and inflammatory indices (PNI, NLR, PLR, SII, SIRI, and CAR) will be calculated from the most recent preoperative laboratory values.

The primary outcome is the occurrence of any Clavien-Dindo grade II or higher postoperative complication within 30 days after surgery. Secondary outcomes include the Comprehensive Complication Index (CCI), length of hospital stay, intensive care unit admission, and 30-day mortality. Multivariable regression analyses will be performed to determine the independent predictive value of each index after adjustment for relevant demographic and clinical variables.

The findings of this study are expected to improve preoperative risk assessment and facilitate identification of patients who may benefit from targeted perioperative optimization strategies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults aged 18 years or older.

  • Patients who underwent bariatric surgery (sleeve gastrectomy, Roux-en-Y gastric bypass, SADI, or SASI).
  • Availability of complete preoperative laboratory data required for calculation of nutritional and inflammatory indices.
  • Availability of postoperative follow-up data for assessment of 30-day complications.

Exclusion criteria

  • Patients younger than 18 years.
  • Missing key preoperative laboratory values required to calculate study indices.
  • Incomplete medical records or unavailable 30-day postoperative outcome data.

Treatment and study plan

bariatric surgery

Procedure

Standard bariatric surgical procedures performed as part of routine clinical care, including sleeve gastrectomy and gastric bypass procedures (Roux-en-Y gastric bypass, SADI, and SASI). No study-specific intervention was assigned.

Primary outcomes

  1. 30-Day Postoperative Complications (Clavien-Dindo Grade II or Higher)

    Time frame: 30 days after surgery

    Occurrence of any postoperative complication classified as Clavien-Dindo grade II or higher within 30 days after bariatric surgery.

Secondary outcomes

  1. Comprehensive Complication Index (CCI)

    Time frame: 30 days after surgery

    Comprehensive Complication Index calculated from all postoperative complications occurring within 30 days after surgery.

  2. Length of Hospital Stay

    Time frame: From surgery until hospital discharge (up to 30 days)

    Total duration of hospitalization following bariatric surgery.

  3. From surgery until hospital discharge (up to 30 days)

    Time frame: 30 days after surgery

    All-cause mortality occurring within 30 days after bariatric surgery.

Sponsors and collaborators

Lead sponsor

G.Gennimatas General Hospital

Other

Registry information

Official study title

The Predictive Value of Nutritional and Inflammatory Indices for Postoperative Complications in Bariatric Surgery Patients: A Single-Centre Retrospective Cohort Study

Acronym: BARI-NUTRI

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Aug 5, 2026
Registry last updated
Aug 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.